Loading…
NXGL
Nexgel Inc
NASDAQ· Healthcare· Medical Instruments & Supplies· CUSIP 65344E107
$0.35+0.60%Price as of Aug 29, 18:43 UTC · updated once a day, after the close
Key metrics
- Market cap
- $3.43M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.7x
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.74
- ROE
- -115.06%
- Profit margin
- -51.26%
- Revenue growth
- +27.80%
- Beta
- 0.77
- 52-week high
- $2.89
- 52-week low
- $0.30
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -93.3% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $1.61 | $4.46 | $2.13 | $1.25 | $2.61 | |
| P/S | 3.4x | 1.2x | 3.9x | 3.2x | 3.4x | 9.4x |
| P/B | 2.8x | 3.2x | 5.9x | 2.8x | 0.9x | 1.2x |
| EPS | -$0.38 | -$0.50 | -$0.56 | -$0.85 | -$1.45 |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CLDICalidi Biotherapeutics, Inc. | $1.32 | — | 0.9x | — | -672.22% | $3.41M |
| TNONTenon Medical, Inc. | $5.00 | — | — | — | -551.19% | $3.34M |
| UPCUniverse Pharmaceuticals INC | $4.90 | — | 0.0x | — | -3.50% | $3.25M |
| SXTP60 Degrees Pharmaceuticals Inc | $1.03 |
About the company
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
- 19
- Langhorne, United States
Company description provided by Yahoo Finance.